MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Anthera Pharmaceuticals Company Profile (NASDAQ:ANTH)

Consensus Ratings for Anthera Pharmaceuticals (NASDAQ:ANTH) (?)
Ratings Breakdown: 1 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $9.75 (31.58% upside)

Analysts' Ratings History for Anthera Pharmaceuticals (NASDAQ:ANTH)
Show:
DateFirmActionRatingPrice TargetActions
5/20/2015Citigroup Inc.UpgradeNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2015Citigroup Inc.UpgradeSell -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/30/2015Piper JaffrayBoost Price Target$7.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2015Jefferies GroupReiterated RatingBuy$18.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/30/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha